Media Coverage
Back to Media CoverageBioverativ executive Rogerio Vivaldi to helm cell therapy producer Sigilon
Sigilon Therapeutics is bringing on Bioverativ’s chief global therapeutic operations officer, Rogerio Vivaldi, M.D., to serve as its CEO.